These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6910479)

  • 1. Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Clin Pathol; 1981 May; 34(5):559-63. PubMed ID: 6910479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of minocycline and rifampin against staphylococci.
    Segreti J; Gvazdinskas LC; Trenholme GM
    Diagn Microbiol Infect Dis; 1989; 12(3):253-5. PubMed ID: 2791487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriological characters of strains of Staphylococcus aureus submitted to a reference laboratory related to methicillin resistance.
    Marples RR; Richardson JF; de Saxe MJ
    J Hyg (Lond); 1986 Apr; 96(2):217-23. PubMed ID: 3634787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
    Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC
    J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus.
    Eng RH; Smith SM; Buccini FJ; Cherubin CE
    J Antimicrob Chemother; 1985 Feb; 15(2):201-7. PubMed ID: 3845078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New trends in the chemotherapy of staphylococcal infections.
    Russo G; Tempera G; Stefani S; Nicoletti G
    Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/gentamicin and imipenem/rifampin against methicillin-resistant Staphylococcus aureus.
    Watanakunakorn C
    Chemotherapy; 1991; 37(4):283-6. PubMed ID: 1790726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus.
    Maple P; Hamilton-Miller J; Brumfitt W
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):622-4. PubMed ID: 2506023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
    Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
    Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
    Lowy FD; Chang DS; Lash PR
    Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1996 Jun; 37(6):1171-5. PubMed ID: 8836820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
    Watanakunakorn C; Tisone JC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.
    McConeghy KW; LaPlante KL
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):1-6. PubMed ID: 20727462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
    Chandrasekar PH; Sluchak JA
    Chemotherapy; 1989; 35(5):333-7. PubMed ID: 2551600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin resistance in methicillin-sensitive and resistant Staphyococcus aureus.
    Kensit JG; Shanson DC
    J Antimicrob Chemother; 1976 Sep; 2(3):311-2. PubMed ID: 1049227
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synergism of ciprofloxacin with beta-lactam antibiotics, gentamicin, minocycline and pipemidic acid].
    Dickgiesser N; in der Stroth S; Wundt W
    Infection; 1986; 14(2):82-5. PubMed ID: 2940188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
    Noel AR; Attwood M; Bowker KE; MacGowan AP
    J Antimicrob Chemother; 2021 Jun; 76(7):1840-1844. PubMed ID: 33975336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.